Terms: = Lung cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Diagnosis
11657 results:
1. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
Kilickap S; Ozturk A; Karadurmus N; Korkmaz T; Yumuk PF; Cicin I; Paydas S; Cilbir E; Sakalar T; Uysal M; Yesil Cinkir H; Uskent N; Demir N; Sakin A; Dursun OU; Aver B; Turhal NS; Keskin S; Tural D; Eralp Y; Bugdayci Basal F; Yasar HA; Sendur MAN; Demirci U; Cubukcu E; Karaagac M; Cakar B; Tatli AM; Yetisyigit T; Urvay S; Gursoy P; Oyan B; Turna ZH; Isikdogan A; Olmez OF; Yazici O; Cabuk D; Seker MM; Unal OU; Meydan N; Okutur SK; Tunali D; Erman M;
Medicine (Baltimore); 2024 May; 103(21):e37972. PubMed ID: 38787994
[TBL] [Abstract] [Full Text] [Related]
2. A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.
Tan VS; Tjong MC; Chan WC; Yan M; Delibasic V; Darling G; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan H; Wright FC; Coburn NG; Louie AV
Support Care Cancer; 2024 May; 32(6):381. PubMed ID: 38787434
[TBL] [Abstract] [Full Text] [Related]
3. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
Li X; Wu D; Tang J; Wu Y
J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a model for predicting upstage in minimally invasive lung adenocarcinoma in Chinese people.
Liao Y; Li Z; Song L; Xue Y; Chen X; Feng G
World J Surg Oncol; 2024 May; 22(1):135. PubMed ID: 38778366
[TBL] [Abstract] [Full Text] [Related]
5. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
Ma H; Wu T; Zhang Q; Ding Q
BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
[TBL] [Abstract] [Full Text] [Related]
6. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
7. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
8. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
[TBL] [Abstract] [Full Text] [Related]
9. Scoping review of exposure questionnaires and surveys in interstitial lung disease.
Barnes H; Elmrayed S; Barber CM; Feary J; Lee CT; Gandhi S; Peters CE; Salisbury ML; Johannson KA
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754906
[TBL] [Abstract] [Full Text] [Related]
10. Non-Small Cell lung cancer, Version 4.2024.
Riely GJ; Wood DE; Ettinger DS; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; DeCamp M; Desai AP; Dilling TJ; Dowell J; Durm GA; Gettinger S; Grotz TE; Gubens MA; Juloori A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Mullikin TC; Ng T; Owen D; Owen DH; Patel SP; Patil T; Polanco PM; Riess J; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory KM; Hang L
J Natl Compr Canc Netw; 2024 May; 22(4):249-274. PubMed ID: 38754467
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of sex inequity in lung-cancer-specific survival.
Lærum D; Strand TE; Brustugun OT; Gallefoss F; Falk R; Durheim MT; Fjellbirkeland L
Acta Oncol; 2024 May; 63():343-350. PubMed ID: 38751329
[TBL] [Abstract] [Full Text] [Related]
12. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer.
Zhang T; Chu L; Tan W; Ye C; Dong H
Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362
[TBL] [Abstract] [Full Text] [Related]
13. [Analysis on the ultrasonic characteristics of tonsillar lymphoma].
Yue B; Zhu JL; Shi CL; Wang M; Wei X
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):457-460. PubMed ID: 38742359
[No Abstract] [Full Text] [Related]
14. [Impact of obesity on the incidence of postoperative pulmonary complications following laparoscopic colorectal surgery].
Wang TH; Li HX; Li BL; Zheng H; Yan T
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1610-1616. PubMed ID: 38742348
[No Abstract] [Full Text] [Related]
15. [Value of peripheral blood rare cell EGFR gene amplification detection in the evaluation of benign and malignant pulmonary nodules].
Li H; Liu XQ; Yan LJ; Liu Y; Zhang JQ; Xiao YN; Li SQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1584-1589. PubMed ID: 38742345
[No Abstract] [Full Text] [Related]
16. [Primary Pulmonary Diffuse Large B-cell Lymphoma Mimics Advanced lung cancer:Report of a Case].
Ito D; Suzuki H; Shomura S
Kyobu Geka; 2024 May; 77(5):389-393. PubMed ID: 38720609
[TBL] [Abstract] [Full Text] [Related]
17. Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis.
Stirling RG; Harrison A; Huang J; Lee V; Taverner J; Barnes H
Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38719736
[TBL] [Abstract] [Full Text] [Related]
18. Relationship between self-psychological adjustment and post-traumatic growth in patients with lung cancer undergoing chemotherapy: a cross-sectional study.
Liu N; Zhang L; Liu Y; Ding X; Li Q; Lixia G; Zhang X
BMJ Open; 2024 May; 14(5):e081940. PubMed ID: 38719309
[TBL] [Abstract] [Full Text] [Related]
19. Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies.
Li Y; Huang T; Redline S; Willett WC; Manson JE; Schernhammer ES; Hu FB
Lancet Diabetes Endocrinol; 2024 Jun; 12(6):404-413. PubMed ID: 38710189
[TBL] [Abstract] [Full Text] [Related]
20. KRAS Allelic Variants in Biliary Tract cancers.
Moffat GT; Hu ZI; Meric-Bernstam F; Kong EK; Pavlick D; Ross JS; Murugesan K; Kwong L; De Armas AD; Korkut A; Javle M; Knox JJ
JAMA Netw Open; 2024 May; 7(5):e249840. PubMed ID: 38709532
[TBL] [Abstract] [Full Text] [Related]
[Next]
